Today’s coverage explores the intersection of neurodevelopmental science and public policy, from a neuroscientist's bid for Congress to the ethical reckoning of historical brain research (Blog Name: Living on the Spectrum).
Neuroscience Expertise in Congressional Policy
From Laboratory to Legislation
Sam Wang, a Princeton neuroscientist and co-founder of the AI-driven autism detection company BlinkLab, has announced his candidacy for the U.S. House of Representatives. Wang’s decision follows recent federal funding cuts and shifts in public health policy, specifically the overhaul of the Interagency Autism Coordinating Committee (IACC). Psychiatry resident Zachary Williams suggests that a representative with specific autism expertise could help shift government focus toward evidence-based policy and provide a necessary check on executive control over scientific agencies.
Personal and Professional Research
Wang’s academic work identifies the cerebellum as a key brain region in autism, a research focus influenced by his personal experience growing up with an autistic sister. While some former officials, such as Walter Koroshetz, argue that effective science advocacy does not strictly require a scientific background, supporters highlight Wang’s ability to mobilize the academic community.
Analytical Approach to Reform
Beyond neurodevelopmental policy, Wang intends to apply his data-driven background to systemic political issues. His platform includes addressing gerrymandering by analyzing district line patterns and pursuing reforms for the Electoral College.
The Legacy of the Yakovlev Brain Collection
Historical Context of Brain Research
Neuroanatomist Paul I. Yakovlev amassed a collection of over 1,000 human brains sourced from residents of state institutions, including the Walter E. Fernald State School for individuals with developmental disabilities. Using a specialized microtome, Yakovlev created 250,000 tissue slides to investigate the mechanical origins of neurological disorders. This work took place during the eugenics movement, a period when institutionalized individuals were frequently treated as biological specimens rather than patients.
Dehumanization and Disability Justice
Disability justice advocate Alex Green argues that the Yakovlev collection represents a systemic dehumanization of people with neurodevelopmental differences. While Yakovlev framed his work as a scientific endeavor, the lack of individual agency for those in the collection highlights the ethical failures of historical medical research. Some scholars now view the collection more as a historical warning regarding medical ethics than a source of modern scientific breakthrough.
Access to Personal Histories
Following a 2025 change in Massachusetts law, archives from these state institutions are now open to the public. This allows families and researchers to reconstruct the personal biographies of individuals previously reduced to medical data. Current institutions, such as the Harvard Brain Tissue Resource Center, continue neurological research but operate under strict modern consent protocols that contrast with the practices of Yakovlev’s era.
Podcast Transcript
Aaron: Hello everyone, and welcome to the podcast. I am Aaron.
Jamie: And I am Jamie.
Aaron: Lately, I have been thinking about how much our understanding of neurodevelopmental differences is shaped by things happening outside the doctor's office. It is not just about therapy or diagnosis; it is also about policy and history. We have two very different stories today that really drive that home.
Jamie: It is true. One looks at how scientific expertise is trying to find a seat at the table where laws are made, and the other looks back at a fairly uncomfortable chapter in medical history that we are only just beginning to fully unpack.
Aaron: Let's start with the first one. I was reading about Sam Wang, a neuroscientist from Princeton. He is actually running for a seat in the U.S. House of Representatives. Jamie, it is not every day you see a high-level brain researcher trading the lab for a campaign trail. What is the driver there?
Jamie: It is quite a shift. Sam Wang is well-known in the research community, particularly for his work on the cerebellum. Traditionally, we thought of the cerebellum as being mostly about motor control, but his research has really highlighted its role in autism. He actually has a personal connection to this, as his sister is autistic. He is moving into the political sphere largely because of concerns over how public health policy and research funding are handled at a federal level.
Aaron: I think for a lot of parents, the idea of having someone in Congress who actually "gets" the science of autism sounds like a relief. Usually, we feel like we are shouting from the outside, trying to explain why certain programs or research funding matter.
Jamie: That is exactly the point many are making. There is this body called the Interagency Autism Coordinating Committee, or the IACC. It is crucial for directing federal autism efforts, and there have been significant changes to how it is structured. Wang’s supporters, including some in the psychiatric community, feel that having a scientist in office could ensure that policy stays evidence-based rather than being shaped by shifting political winds.
Aaron: I noticed he is also involved in a company called BlinkLab that uses AI for early detection. It makes me wonder—if someone with that background is in power, could we see a faster bridge between "cutting-edge research" and "actual help for families"? Or is that being too optimistic?
Jamie: It is a complex question. While his expertise is specialized, being one person in a large legislative body is different from being in a lab. However, the hope is that he can act as a translator of sorts. He is also looking at broader issues like how data and analytical models can be used to fix things like gerrymandering. It is really about bringing a "scientific mind" to the way a country is run.
Aaron: Speaking of how things are run, it makes me think about the history of how we got here. Sometimes we forget that the "evidence" we rely on today has a history that isn't always clean. I was looking into this story about Paul Yakovlev and those thousands of brain specimens. It is a bit unsettling to think about.
Jamie: It is a heavy topic. Paul Yakovlev was a neuroanatomist who created a massive collection of brain slices—about 250,000 slides. Most of these came from people who lived in state institutions, like the Fernald State School in Massachusetts. These were individuals with developmental and psychiatric disabilities who, during that era, were often treated more like research material than patients.
Aaron: I read that they used a tool called a microtome to cut the tissue into these incredibly thin slices. At the time, I suppose they thought they were doing great science, but from a modern perspective, the lack of consent is what really stands out to me. These people didn't choose to be part of a "collection."
Jamie: You’re touching on the core of the controversy. This was an era influenced by eugenics—the idea that some lives were less valuable than others. For Yakovlev, this was a scientific "hobby," but for disability justice advocates today, it represents a systemic dehumanization. These individuals were often nameless in the records, reduced to their brain anatomy.
Aaron: But there is a bit of a turning point recently, right? Something about archives being opened in Massachusetts?
Jamie: Yes, a change in state law in 2025 has started to open these institutional archives. It allows families and researchers to finally look at the people behind the specimens. It is a move toward "restorative history"—giving these individuals their names and stories back, rather than just seeing them as a slide under a microscope.
Aaron: It is a strange tension. On one hand, we want scientific progress, but on the other, the cost of that progress matters. Does this collection still have value today, or is it just a reminder of what not to do?
Jamie: Some scientists still use it to study things like the mechanical basis of disorders, but many scholars now argue its greatest value is as a "historical warning." Modern institutions, like the Harvard Brain Tissue Resource Center, do similar research now, but with incredibly strict ethical protocols and informed consent. It shows how much our respect for individual autonomy has grown.
Aaron: It really brings us full circle. Whether it is a scientist running for office to protect current research or families looking into the past to reclaim their ancestors' dignity, it is all about recognizing the person behind the diagnosis.
Jamie: Exactly. It is about moving from a world where people with neurodevelopmental differences were "studied" to a world where they are "heard."
Aaron: That is a good place to pause for today. It is a lot to sit with, but these stories help us see the bigger picture of the community we care about.
Jamie: It really does.
Aaron: Thank you for joining us. If you want to dive deeper into the details of Sam Wang's work or the history of the Yakovlev collection, you can find the article summaries and the original links on our episode page.
Jamie: We'll see you next time. Goodbye.
Aaron: Goodbye.